Replies to post #217654 on Biotech Values

[Whalatane]

MYOK ...Nowlurking ...Paradigm -HF was an Outcome trial .. Entresto is a combination drug ( Sacubitril / Valsartan ). I do not know the history of Sacubitril but Valsartan was approved in 2002 .

The MYOK trial you referred to is designed with FDA input and accepted by them . There will be a long term safety follow up for this trial . Its not an Outcome trial .

I intend to stay long into the March 10th ACC data presentation .
Kiwi

[Whalatane]

MYOK. https://globenewswire.com/news-release/2018/03/08/1418754/0/en/MyoKardia-Announces-Positive-Results-from-Low-Dose-Cohort-of-Phase-2-PIONEER-HCM-Study-of-Mavacamten-in-Symptomatic-Obstructive-Hypertrophic-Cardiomyopathy-Patients.html?print=1

Kiwi